Posian Pharma Private Limited - Due diligence report
A 360° intelligence report on Posian Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and d…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Posian Pharma Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsPosian Pharma Private Limited is assessed as Moderate with a Trust Score of 73/100. Posian Pharma Private Limited is an active private limited indian non-government company incorporated in 2010, operating in the Chemicals sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and high financial risk profile.
Report generated on 23 Nov 2026 from the latest processed filings. Posian Pharma Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 0 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Negative operating earnings - debt service depends on external support.
- No open charges - unencumbered balance sheet.
- Working-capital cover adequate.
Charges position: 0 open ( 48.0 cr ) · 0 satisfied ( 12.5 cr ).
- Company status is Active as per MCA.
- Balance sheet slightly behind (Mar 2025).
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| SAMIR KUMAR PAIKARAY | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Shubhrajyoti Panda | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| Nalini Kanta Panda | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 3 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
Ownership & Group Intelligence
As per FY 2017 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth N/A · Distress 90Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance record supports lending.
- No clear growth signals in the filed years.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 8 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Crystal Di-Electrics And Polymers Private Limited | U00300KA1990PTC011270 | Bangalore, Karnataka, India |
| Luna Health Care Private Limited | U51397WB2003PTC097007 | 24 Pgs (N), West Bengal, India |
| Helzon Pharmaceuticals Pvt Ltd | U24299WB1996PTC079832 | Kolkata, West Bengal, India |
| Sipra Industries Private Limited | U24231JH1987PTC002517 | Ranchi, Jharkhand, India |
| Navrang Paints Private Limited | U24222RJ1995PTC010040 | Udaipur, Rajasthan, India |
| Decent Polyplast Private Limited | U25200DL2008PTC178026 | Delhi, Delhi, India |
| Nezone Medicines Private Limited | U24232AS2002PTC006795 | Guwahati, Assam, India |
| Om Sri Godavari Agrochem Private Limited | U24219TG2008PTC058788 | Hyderabad, Telangana, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Posian Pharma Private Limited before audits and certifications: compliance score 88/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Posian Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 50/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Limited indicators at present. Growth score n/a, margin trends, ownership structure and peer set for Posian Pharma Private Limited - screening before a deeper diligence.
Vendor verdict: Favourable indicators. Trust score 73/100, distress signals and MSME payment-delay disclosures - know whether Posian Pharma Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Posian Pharma Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Posian Pharma Private Limited an active company?
Posian Pharma Private Limited has MCA status “Active” with a compliance score of 88/100 (Low Risk).
Is Posian Pharma Private Limited financially healthy?
Posian Pharma Private Limited has a Financial Health Score of 20/100 (Caution Indicated) based on its filed financial statements.
Should I do business with Posian Pharma Private Limited?
Its overall Trust Score is 73/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Posian Pharma Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.
Does Posian Pharma Private Limited have loans or charges against its assets?
No charges are registered against this company - an unencumbered balance sheet.
Is Posian Pharma Private Limited up to date with its ROC filings?
Balance sheet slightly behind (Mar 2025). Overall compliance score: 88/100 (Low Risk).
Is it risky to lend to Posian Pharma Private Limited?
Its Credit Risk Score is 50/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.